Intracellular metabolite β-glucosylceramide is an endogenous Mincle ligand possessing immunostimulatory activity
Open accessThe DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Abstract
Significance: Sensing tissue damage is a crucial function of pattern recognition receptors (PRRs). However, endogenous ligand recognition by PRRs is not well documented. Macrophage inducible C-type lectin (Mincle) is a PRR that recognizes both pathogens and damaged cells. In this study, we isolated endogenous glycolipids derived from damaged cells and identified a ubiquitous intracellular metabolite, β-glucosylceramide (GlcCer), as a Mincle ligand. β-GlcCer induced inflammatory and acquired immune responses via Mincle on myeloid cells. Accumulation of β-GlcCer leads to Gaucher disease, a disorder characterized mainly by systemic inflammation. In a Gaucher model in which mice are deficient in the β-GlcCer–degrading enzyme, further deletion of the Mincle gene attenuated inflammatory responses. These results suggest that β-GlcCer is an endogenous Mincle ligand and acts as an immunostimulatory factor upon cell damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HMDB 3.0—The Human Metabolome Database in 2013
Wishart, D. S., Jewison, T., Guo, A. C., Wilson, M., Knox, C., Liu, Y., Djoumbou, Y., Mandal, R., Aziat, F., Dong, E., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1065 · Cited by 2,845
Mazzulli, J. R., Xu, Y.-H., Sun, Y., Knight, A. L., McLean, P. J., Caldwell, G. A., Sidransky, E., Grabowski, G. A., & Krainc, D. (2011) · Cell · doi:10.1016/j.cell.2011.06.001 · Cited by 1,341 · cited 1×
“It has been hypothesized that this results from the ability of β-GlcCer to promote neurotoxic amyloid formation (73, 74).”
BackgroundRavetch, J. V., & Lanier, L. L. (2000) · Science · doi:10.1126/science.290.5489.84 · Cited by 1,283 · cited 1×
“Alternatively, a subtle continuous recognition of a low-level ligand by activating receptors might counterbalance inhibitory receptors that are constantly recognizing normal self (47).”
BackgroundDirect recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle
Ishikawa, E., Ishikawa, T., Morita, Y. S., Toyonaga, K., Yamada, H., Takeuchi, O., Kinoshita, T., Akira, S., Yoshikai, Y., & Yamasaki, S. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20091750 · Cited by 792
Self-citationMincle is an ITAM-coupled activating receptor that senses damaged cells
Yamasaki, S., Ishikawa, E., Sakuma, M., Hara, H., Ogata, K., & Saito, T. (2008) · Nature Immunology · doi:10.1038/ni.1651 · Cited by 740 · cited 6×
“A model system with which to study this phenomenon involves whole-body irradiation of mice, which induces massive death of thymocytes and consequently elicits transient infiltration of neutrophils into the thymus (5) (Fig.”
BackgroundMethodResultInfluentialSelf-citationGaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)
Hruska, K. S., LaMarca, M. E., Scott, C. R., & Sidransky, E. (2008) · Human Mutation · doi:10.1002/humu.20676 · Cited by 678 · cited 1×
“In fact, a homozygous mutation in human β-glucocerebrosidase (GBA1), a crucial enzyme degrading β-GlcCer, leads to Gaucher disease because of a reduction in enzyme activity that causes accumulation of β-GlcCer (19).”
BackgroundMutations in the Glucocerebrosidase Gene and Parkinson's Disease in Ashkenazi Jews
Aharon-Peretz, J., Rosenbaum, H., & Gershoni-Baruch, R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033277 · Cited by 597 · cited 1×
“In addition to Gaucher disease, GBA1 mutation is genetically correlated with Parkinson’s disease (72).”
BackgroundThe granulomatous inflammatory response. A review.
Adams, D. O. (1976) · PubMed · Cited by 550
LIMP-2 Is a Receptor for Lysosomal Mannose-6-Phosphate-Independent Targeting of β-Glucocerebrosidase
Reczek, D., Schwake, M., Schröder, J., Hughes, H., Blanz, J., Jin, X., Brondyk, W., Van Patten, S., Edmunds, T., & Saftig, P. (2007) · Cell · doi:10.1016/j.cell.2007.10.018 · Cited by 542
Recognition of Endogenous Nucleic Acids by the Innate Immune System
Roers, A., Hiller, B., & Hornung, V. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.002 · Cited by 541
Schoenen, H., Bodendorfer, B., Hitchens, K., Manzanero, S., Werninghaus, K., Nimmerjahn, F., Agger, E. M., Stenger, S., Andersen, P., Ruland, J., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904013 · Cited by 492
Characterization of Ceramide Synthase 2
Laviad, E. L., Albee, L., Pankova-Kholmyansky, I., Epstein, S., Park, H., Merrill, A. H., & Futerman, A. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707386200 · Cited by 466
C-type lectin Mincle is an activating receptor for pathogenic fungus, Malassezia
Yamasaki, S., Matsumoto, M., Takeuchi, O., Matsuzawa, T., Ishikawa, E., Sakuma, M., Tateno, H., Uno, J., Hirabayashi, J., Mikami, Y., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805177106 · Cited by 424 · cited 2×
“Interestingly, Mincle is involved in the immune response against fungi that causes skin disease (41) through the recognition of its unique glycolipids (7, 42).”
BackgroundSelf-citationAhrens, S., Zelenay, S., Sancho, D., Hanč, P., Kjær, S., Feest, C., Fletcher, G., Durkin, C., Postigo, A., Skehel, M., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.008 · Cited by 398 · cited 1×
“For the same reason, the precise contribution of F-actin as a Clec9a ligand (49, 50) is difficult to prove by gene-deletion approaches, because actin is an indispensable cytoskeletal protein.”
BackgroundGlycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide
D’Angelo, G., Polishchuk, E., Tullio, G. D., Santoro, M., Campli, A. D., Godi, A., West, G., Bielawski, J., Chuang, C.-C., van der Spoel, A. C., et al. (2007) · Nature · doi:10.1038/nature06097 · Cited by 398
Hara, H., Ishihara, C., Takeuchi, A., Imanishi, T., Xue, L., Morris, S. W., Inui, M., Takai, T., Shibuya, A., Saijo, S., et al. (2007) · Nature Immunology · doi:10.1038/ni1466 · Cited by 351 · cited 2×
“Hara, Kagoshima University, Kagoshima, Japan (76).”
The Dendritic Cell Receptor Clec9A Binds Damaged Cells via Exposed Actin Filaments
Zhang, J.-G., Czabotar, P. E., Policheni, A. N., Caminschi, I., San Wan, S., Kitsoulis, S., Tullett, K. M., Robin, A. Y., Brammananth, R., van Delft, M. F., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.009 · Cited by 342 · cited 1×
“For the same reason, the precise contribution of F-actin as a Clec9a ligand (49, 50) is difficult to prove by gene-deletion approaches, because actin is an indispensable cytoskeletal protein.”
BackgroundDavidsen, J., Rosenkrands, I., Christensen, D., Vangala, A., Kirby, D., Perrie, Y., Agger, E. M., & Andersen, P. (2005) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2005.10.011 · Cited by 341
Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals
Brennan, P. J., Tatituri, R. V. V., Brigl, M., Kim, E. Y., Tuli, A., Sanderson, J. P., Gadola, S. D., Hsu, F.-F., Besra, G. S., & Brenner, M. B. (2011) · Nature Immunology · doi:10.1038/ni.2143 · Cited by 326 · cited 2×
“β-GlcCer has also been reported to be an activator of NKT cells (46, 54).”
BackgroundWerninghaus, K., Babiak, A., Groß, O., Hölscher, C., Dietrich, H., Agger, E. M., Mages, J., Mocsai, A., Schoenen, H., Finger, K., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081445 · Cited by 315
Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene
Tybulewicz, V. L. J., Tremblay, M. L., LaMarca, Willemsen, R., Stubblefield, B. K., Winfield, S., Zablocka, B., Sidransky, E., Martin, B. M., Huang, S. P., et al. (1992) · Nature · doi:10.1038/357407a0 · Cited by 308 · cited 2×
“GBA1-deficient mice (32) were purchased from the Jackson Laboratory.”
MethodHolleran, W. M., Ginns, E. I., Menon, G. K., Grundmann, J. U., Fartasch, M., McKinney, C. E., Elias, P. M., & Sidransky, E. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117160 · Cited by 285 · cited 1×
“For example, the neonatal lethality of GBA1 mice, which is mainly because of a keratinocyte disorder (68, 69), was not rescued on a Mincle-deficient background.”
BackgroundPre- and post-Golgi translocation of glucosylceramide in glycosphingolipid synthesis
Halter, D., Neumann, S., van Dijk, S. M., Wolthoorn, J., de Mazière, A. M., Vieira, O. V., Mattjus, P., Klumperman, J., van Meer, G., & Sprong, H. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200704091 · Cited by 269
Resistance of Fc receptor- deficient mice to fatal glomerulonephritis.
Park, S. Y., Ueda, S., Ohno, H., Hamano, Y., Tanaka, M., Shiratori, T., Yamazaki, T., Arase, H., Arase, N., Karasawa, A., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3256 · Cited by 263
C-type lectin receptors in the control of T helper cell differentiation
Geijtenbeek, T. B. H., & Gringhuis, S. I. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.55 · Cited by 257
Ishikawa, T., Itoh, F., Yoshida, S., Saijo, S., Matsuzawa, T., Gonoi, T., Saito, T., Okawa, Y., Shibata, N., Miyamoto, T., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.03.008 · Cited by 246 · cited 3×
“Interestingly, Mincle is involved in the immune response against fungi that causes skin disease (41) through the recognition of its unique glycolipids (7, 42).”
BackgroundMethodSelf-citationMistry, P. K., Liu, J., Yang, M., Nottoli, T., McGrath, J., Jain, D., Zhang, K., Keutzer, J., Chuang, W.-L., Mehal, W. Z., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003308107 · Cited by 245
Unleashing the therapeutic potential of NOD-like receptors
Geddes, K., Magalhães, J. G., & Girardin, S. E. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2783 · Cited by 232
Kain, L., Webb, B., Anderson, B. L., Deng, S., Holt, M., Costanzo, A., Zhao, M., Self, K., Teyton, A., Everett, C., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.08.017 · Cited by 232 · cited 1×
“However, two recent reports proposed that the activator might be α-GlcCer, as the activity was not influenced by treatment with β-glucosidase (55, 56).”
BackgroundMiyake, Y., Toyonaga, K., Mori, D., Kakuta, S., Hoshino, Y., Oyamada, A., Yamada, H., Ono, K.-I., Suyama, M., Iwakura, Y., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.03.010 · Cited by 229 · cited 1×
“The 2B4-NFAT-GFP reporter cells expressingMincle,MCL,Dectin-2, orDCAR were prepared as previously described (5, 7, 62).”
MethodSelf-citationIezzi, G., Sonderegger, I., Ampenberger, F., Schmitz, N., Marsland, B. J., & Kopf, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810769106 · Cited by 203
Neumann, K., Castiñeiras-Vilariño, M., Höckendorf, U., Hannesschläger, N., Lemeer, S., Kupka, D., Meyermann, S., Lech, M., Anders, H.-J., Kuster, B., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.12.015 · Cited by 203 · cited 1×
“Some other CLRs recognize crystallized self-components that do not exist under normal conditions (51, 52).”
BackgroundMurine models of acute neuronopathic Gaucher disease
Enquist, I. B., Bianco, C. L., Ooka, A., Nilsson, E., Månsson, J.-E., Ehinger, M., Richter, J., Brady, R. O., Kirik, D., & Karlsson, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708086104 · Cited by 198
Yap, T. L., Gruschus, J. M., Velayati, A., Westbroek, W., Goldin, E., Moaven, N., Sidransky, E., & Lee, J. C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.237859 · Cited by 174 · cited 1×
“It has been hypothesized that this results from the ability of β-GlcCer to promote neurotoxic amyloid formation (73, 74).”
BackgroundYamaji, T., & Hanada, K. (2015) · Traffic · doi:10.1111/tra.12239 · Cited by 171
Self-citationHuman Epidermal Glucosylceramides are Major Precursors of Stratum Corneum Ceramides
Hamanaka, S., Suzuki, A., Hara, M., Nishio, H., Otsuka, F., & Uchida, Y. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01836.x · Cited by 168 · cited 1×
“As another example, epidermis has a unique GlcCer epidermoside, which is composed of a longer unsaturated ω-hydroxy FA that functions to maintain the epidermal permeability barrier (39, 40).”
BackgroundStructural analysis for glycolipid recognition by the C-type lectins Mincle and MCL
Furukawa, A., Kamishikiryo, J., Mori, D., Toyonaga, K., Okabe, Y., Toji, A., Kanda, R., Miyake, Y., Ose, T., Yamasaki, S., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312649110 · Cited by 167
Self-citationNew insights on glucosylated lipids: Metabolism and functions
Ishibashi, Y., Kohyama‐Koganeya, A., & Hirabayashi, Y. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.06.001 · Cited by 166 · cited 1×
“, length and saturation) differs among tissues (18, 36).”
BackgroundHuman Mincle Binds to Cholesterol Crystals and Triggers Innate Immune Responses
Kiyotake, R., Oh‐hora, M., Ishikawa, E., Miyamoto, T., Ishibashi, T., & Yamasaki, S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.645234 · Cited by 156 · cited 1×
“Some other CLRs recognize crystallized self-components that do not exist under normal conditions (51, 52).”
BackgroundSelf-citationVitner, E. B., Farfel-Becker, T., Eilam, R., Biton, I., & Futerman, A. H. (2012) · Brain · doi:10.1093/brain/aws095 · Cited by 149
Sidransky, E., Sherer, D. M., & Ginns, E. I. (1992) · Pediatric Research · doi:10.1203/00006450-199210000-00023 · Cited by 146 · cited 1×
“For example, the neonatal lethality of GBA1 mice, which is mainly because of a keratinocyte disorder (68, 69), was not rescued on a Mincle-deficient background.”
BackgroundSymolon, H., Schmelz, E. M., Dillehay, D. L., & Merrill, A. H. (2004) · Journal of Nutrition · doi:10.1093/jn/134.5.1157 · Cited by 143
Mechanism for Recognition of an Unusual Mycobacterial Glycolipid by the Macrophage Receptor Mincle
Feinberg, H., Jégouzo, S. A. F., Rowntree, T. J. W., Guan, Y., Brash, M. A., Taylor, M. E., Weis, W. I., & Drickamer, K. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.497149 · Cited by 141 · cited 1×
“It remains unclear why the unsaturated β-GlcCer C24:1(15Z) possesses the most potent ligand activity, as the crystal structure of Mincle (9, 10, 12) suggested that the double bond of C24:1 is likely to be located away from the Mincle interacting site.”
BackgroundCytokines of the γc family control CD4+ T cell differentiation and function
Yamane, H., & Paul, W. E. (2012) · Nature Immunology · doi:10.1038/ni.2431 · Cited by 128 · cited 1×
“In addition, the different stimulus strength during T-cell priming is reported to alter Th orientation (67), which may explain the apparent contradictory results between in vitro vs.”
ResultSystemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage
Mizukami, H., Mi, Y., Wada, R., Kono, M., Yamashita, T., Liu, Y., Werth, N., Sandhoff, R., Sandhoff, K., & Proia, R. L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214530 · Cited by 125
Yamada, T., Uchikata, T., Sakamoto, S., Yokoi, Y., Fukusaki, E., & Bamba, T. (2013) · Journal of Chromatography A · doi:10.1016/j.chroma.2013.01.078 · Cited by 124 · cited 1×
“We next analyzed fraction 4-11 by electron spray ionizationquadrupole Orbitrap mass spectrometry (ESI-Q-Orbitrap-MS) (25).”
MethodSelf-citationC-Type Lectin Receptor MCL Facilitates Mincle Expression and Signaling through Complex Formation
Miyake, Y., Oh‐hora, M., & Yamasaki, S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402429 · Cited by 121 · cited 1×
“Mincle Tg mice were previously described (77).”
Self-citationIntegrity and Barrier Function of the Epidermis Critically Depend on Glucosylceramide Synthesis
Jennemann, R., Sandhoff, R., Langbein, L., Kaden, S., Rothermel, U., Gallala, H., Sandhoff, K., Wiegandt, H., & Gröne, H.-J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610304200 · Cited by 118 · cited 1×
“As another example, epidermis has a unique GlcCer epidermoside, which is composed of a longer unsaturated ω-hydroxy FA that functions to maintain the epidermal permeability barrier (39, 40).”
BackgroundOstrop, J., Jozefowski, K., Zimmermann, S., Hofmann, K., Strasser, E. F., Lepenies, B., & Lang, R. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500102 · Cited by 114 · cited 1×
“β-GlcCer is localized in endoplasmic reticulum/Golgi in healthy cells, whereas Mincle is expressed not only on the cell surface but also in intracellular compartments, such as endosomes or lysosomes (48).”
BackgroundActivation of iNKT cells by a distinct constituent of the endogenous glucosylceramide fraction
Brennan, P. J., Tatituri, R. V. V., Heiß, C., Watts, G. F. M., Hsu, F., Veerapen, N., Cox, L. R., Azadi, P., Besra, G. S., & Brenner, M. B. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415357111 · Cited by 112 · cited 1×
“However, two recent reports proposed that the activator might be α-GlcCer, as the activity was not influenced by treatment with β-glucosidase (55, 56).”
BackgroundHsu, F.-F., Turk, J., Stewart, M. E., & Downing, D. T. (2002) · Journal of the American Society for Mass Spectrometry · doi:10.1016/s1044-0305(02)00362-8 · Cited by 108 · cited 1×
“2683) (26), the loss of a glycosyl residue (m/z 520.”
BackgroundBoutin, M., Sun, Y., Shacka, J. J., & Auray‐Blais, C. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b04227 · Cited by 92 · cited 2×
“Another central characteristic of this disorder is neurodegeneration (70), raising the possibility that Mincle expressed on microglia (71) contributes to this pathology, as the most active β-GlcCer species C24:1 is abundantly expressed in brain (36, 37).”
BackgroundZigmond, E., Preston, S., Pappo, O., Lalazar, G., Margalit, M., Shalev, Z., Zolotarov, L., Friedman, D., Alper, R., & Ilan, Y. (2006) · Gut · doi:10.1136/gut.2006.095497 · Cited by 92 · cited 1×
“β-GlcCer has also been reported to be an activator of NKT cells (46, 54).”
BackgroundHattori, Y., Morita, D., Fujiwara, N., Mori, D., Nakamura, T., Harashima, H., Yamasaki, S., & Sugita, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.566489 · Cited by 90
Self-citationFelding‐Habermann, B., Igarashi, Y., Fenderson, B. A., Park, L. S., Radin, N. S., Inokuchi, J., Strassmann, G., Handa, K., & Hakomori, S. (1990) · Biochemistry · doi:10.1021/bi00478a028 · Cited by 90 · cited 1×
“To determine whether this activation is indeed mediated by β-GlcCer, D-threo-1-phenyl-2-decanoylamino-3-morpholino-1propanol (D-PDMP), an inhibitor of the UDP-glucose ceramide synthase (UGCG) (31), was added during the culture period.”
BackgroundRecent developments in the immunology and biology ofMalasseziaspecies
Ashbee, H. R. (2006) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2006.00057.x · Cited by 90
Sensing of cell death by myeloid C-type lectin receptors
Sancho, D., & Reis e Sousa, C. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.12.007 · Cited by 88
Hanč, P., Fujii, T., Iborra, S., Yamada, Y., Huotari, J., Schulz, O., Ahrens, S., Kjær, S., Way, M., Sancho, D., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.04.009 · Cited by 86 · cited 1×
“Further understanding of the principles of self-recognition via CLRs will require the structural analysis of various CLR-ligand complexes (53).”
BackgroundCabrera-Salazar, M. A., DeRiso, M., Bercury, S. D., Li, L., Lydon, J. T., Weber, W., Pande, N., Cromwell, M. A., Copeland, D., Leonard, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043310 · Cited by 80 · cited 1×
“Another central characteristic of this disorder is neurodegeneration (70), raising the possibility that Mincle expressed on microglia (71) contributes to this pathology, as the most active β-GlcCer species C24:1 is abundantly expressed in brain (36, 37).”
BackgroundFeinberg, H., Rambaruth, N. D. S., Jégouzo, S. A. F., Jacobsen, K. M., Djurhuus, R., Poulsen, T. B., Weis, W. I., Taylor, M. E., & Drickamer, K. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.749515 · Cited by 80
Burrow, T. A., Sun, Y., Prada, C. E., Bailey, L., Zhang, W., Brewer, A., Wu, S. W., Setchell, K. D. R., Witte, D., Cohen, M. B., et al. (2015) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2014.08.011 · Cited by 70 · cited 1×
“C24:1 is abundantly expressed in brain tissue (36, 37) and accumulates greatly in Gaucher disease patients (38).”
BackgroundCorynomycolic acid-containing glycolipids signal through the pattern recognition receptor Mincle
van der Peet, P. L., Gunawan, C., Torigoe, S., Yamasaki, S., & Williams, S. J. (2015) · Chemical Communications · doi:10.1039/c5cc00085h · Cited by 66
Self-citationOn One Leg: Trehalose Monoesters Activate Macrophages in a Mincle‐Dependent Manner
Stocker, B. L., Khan, A. A., Chee, S. H., Kamena, F., & Timmer, M. S. M. (2014) · ChemBioChem · doi:10.1002/cbic.201300674 · Cited by 62
Huber, A., Kallerup, R. S., Korsholm, K. S., Franzyk, H., Lepenies, B., Christensen, D., Foged, C., & Lang, R. (2016) · Innate Immunity · doi:10.1177/1753425916651132 · Cited by 57
Defining the conformation of human mincle that interacts with mycobacterial trehalose dimycolate
Jégouzo, S. A. F., Harding, E. C., Acton, O. J., Rex, M. J., Fadden, A. J., Taylor, M. E., & Drickamer, K. (2014) · Glycobiology · doi:10.1093/glycob/cwu072 · Cited by 54 · cited 1×
“Given that glycolipids with longer FA have potent activities (10, 11, 34, 35), epidermosides might be recognized by Mincle on dermal Mφ/DCs and thereby modulate immune responses in skin.”
BackgroundRegulation of Glycosphingolipid Metabolism in Liver during the Acute Phase Response
Memon, R. A., Holleran, W. M., Uchida, Y., Moser, A. H., Ichikawa, S., Hirabayashi, Y., Grünfeld, C., & Feingold, K. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19707 · Cited by 54 · cited 1×
“Furthermore, β-GlcCer synthesis is increased in cells that have sustained damage (16, 46).”
BackgroundInnate Immune Response Gene Expression Profiles of N9 Microglia Are Pathogen-Type Specific
McKimmie, C. S., Roy, D., Forster, T., & Fazakerley, J. K. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.03.012 · Cited by 51 · cited 1×
“Another central characteristic of this disorder is neurodegeneration (70), raising the possibility that Mincle expressed on microglia (71) contributes to this pathology, as the most active β-GlcCer species C24:1 is abundantly expressed in brain (36, 37).”
BackgroundRichardson, M. B., Torigoe, S., Yamasaki, S., & Williams, S. J. (2015) · Chemical Communications · doi:10.1039/c5cc04773k · Cited by 48 · cited 1×
“Given that glycolipids with longer FA have potent activities (10, 11, 34, 35), epidermosides might be recognized by Mincle on dermal Mφ/DCs and thereby modulate immune responses in skin.”
BackgroundSelf-citationStructure Determination of Glucosylβ1-N-(ω-O-Linoleoyl)-Acylsphingosines of Human Epidermis
Hamanaka, S., Asagami, C., Suzuki, M., Inagaki, F., & Suzuki, A. (1989) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a122727 · Cited by 46
Groener, J. E. M., Poorthuis, B. J. H. M., Kuiper, S. Z., Hollak, C. E. M., & Aerts, J. M. F. G. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.11.004 · Cited by 46 · cited 1×
“The average concentration of β-GlcCer in sera is in the nanomolar range in healthy individuals; in patients and in GBA1deficient mice, β-GlcCer levels are elevated (44, 45) (Fig.”
BackgroundHomeostatic inflammation in innate immunity
Miyake, K., & Kaisho, T. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.08.003 · Cited by 32
Koerner, T. A. W., Cary, L. W., Li, S.-C., & Li, Y. T. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30224-7 · Cited by 32
Oku, H., Li, C., Shimatani, M., Iwasaki, H., Toda, T., Okabe, T., & Watanabe, H. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0896-2 · Cited by 25
Inafuku, M., Li, C., Kanda, Y., Kawamura, T., Takeda, K., Oku, H., & Watanabe, H. (2012) · Lipids · doi:10.1007/s11745-012-3666-1 · Cited by 19
Cited by
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
Gong, T., Liu, L., Jiang, W., & Zhou, R. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0215-7 · Cited by 1,672
C-type lectins in immunity and homeostasis
Brown, G. D., Willment, J. A., & Whitehead, L. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0004-8 · Cited by 744
GBA Variants and Parkinson Disease: Mechanisms and Treatments
Smith, L., & Schapira, A. H. V. (2022) · Cells · doi:10.3390/cells11081261 · Cited by 256
Osteocyte necrosis triggers osteoclast-mediated bone loss through macrophage-inducible C-type lectin
Andreev, D., Liu, M., Weidner, D., Kachler, K., Faas, M., Grüneboom, A., Schlötzer-Schrehardt, U., Muñoz, L. E., Steffen, U., Grötsch, B., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134214 · Cited by 188
Iizasa, E., Chuma, Y., Uematsu, T., Kubota, M., Kawaguchi, H., Umemura, M., Toyonaga, K., Kiyohara, H., Yano, I., Colonna, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22620-3 · Cited by 92
Self-citation
Metadata
- Authors
- Nagata, M., Izumi, Y., Ishikawa, E., Kiyotake, R., Doi, R., Iwai, S., Omahdi, Z., Yamaji, T., Miyamoto, T., Bamba, T., & Yamasaki, S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2017-04-03
- Volume
- 114
- Issue
- 16
- Pages
- E3285-E3294
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2604816124
- Cited by
- 172
- References
- 74
- FWCI
- 6.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.